Nephros Inc (NEPH) — 8-K Filings

All 8-K filings from Nephros Inc. Browse 13 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (13)

  • 8-K Filing — Nov 26, 2025
  • Nephros Inc. Files 8-K on Financials — Aug 11, 2025 Risk: low
    Nephros Inc. filed an 8-K on August 11, 2025, reporting on results of operations and financial condition as of August 7, 2025. The filing includes financial sta
  • Nephros Inc. Reports on Shareholder Vote Matters — Jun 16, 2025 Risk: low
    Nephros, Inc. filed an 8-K on June 16, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain details about specifi
  • Nephros Inc. Files 8-K on Financials — May 8, 2025 Risk: low
    Nephros Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. The f
  • Nephros Inc. Appoints New Chief Medical Officer — Apr 28, 2025 Risk: medium
    Nephros Inc. announced on April 23, 2025, the appointment of Dr. Michael J. Z. Brown as Chief Medical Officer. Dr. Brown brings extensive experience in nephrolo
  • 8-K Filing — Apr 1, 2025
  • Nephros Inc. Files 8-K on Financials — Mar 6, 2025 Risk: low
    On March 6, 2025, Nephros, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as finan
  • Nephros Inc. Board Changes and Officer Compensation Update — Mar 4, 2025 Risk: medium
    Nephros Inc. announced on February 26, 2025, a change in its board of directors. Specifically, the company reported the departure of a director and the election
  • Nephros Inc. Files 8-K for Financial Results — Nov 13, 2024 Risk: low
    On November 7, 2024, Nephros Inc. reported its financial results for the period ending November 7, 2024. The filing details the company's operational and financ
  • Nephros Inc. Files 8-K Report — Aug 26, 2024 Risk: low
    On August 26, 2024, Nephros Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update rather than a
  • Nephros Inc. to Acquire Med-Tech Services for $10.5M — May 24, 2024 Risk: medium
    Nephros Inc. announced on May 23, 2024, that it has entered into a definitive agreement to acquire all outstanding equity interests of Med-Tech Services, Inc. f
  • Nephros Inc. Files 8-K with Financial Updates — May 1, 2024 Risk: low
    On May 1, 2024, Nephros Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating updates or disclosures related to
  • Nephros Inc. Files 8-K for Operations and Financials — Mar 7, 2024 Risk: low
    Nephros, Inc. filed an 8-K on March 7, 2024, to report on its results of operations and financial condition, as well as to file financial statements and exhibit

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.